Fig. 2From: A cross-sectional survey on the early impact of COVID-19 on the uptake of decentralised trial methods in the conduct of clinical trialsPercentage of trials in which some decentralised methods are implemented (not completely decentralised trials). *Respondents that did not answer this question are left blank in figureBack to article page